Daratumumab with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)

Technology appraisal
Reference number: TA454
Published: 05 July 2017

History

Invitation to participate

Final scope (PDF 86 KB)

Published:

14 December 2016
Final matrix (PDF 89 KB)

Published:

14 December 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 123 KB)

Published:

14 December 2016

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft matrix post referral (PDF 99 KB)

Published:

04 August 2017
Draft scope post referral (PDF 118 KB)

Published:

04 August 2017